These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15913812)

  • 21. Effect of antispastic agents (calcium antagonists and/or isosorbide dinitrate) on high-sensitivity C-reactive protein in patients with coronary vasospastic angina pectoris and no hemodynamically significant coronary artery disease.
    Hung MJ; Cherng WJ; Cheng CW; Yang NI
    Am J Cardiol; 2005 Jan; 95(1):84-7. PubMed ID: 15619396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The value of intravenous trinitrin in unstable angina].
    Page A; Gateau P; Ohayon J; Coupillaud J; Le Minh D; Besse P
    Arch Mal Coeur Vaiss; 1982 Mar; 75(3):325-31. PubMed ID: 6807249
    [No Abstract]   [Full Text] [Related]  

  • 23. [Combined anterior and inferior ST-segment elevation during exercise test: a case report].
    Aribaş A; Sarigüzel MA; Ozdil H
    Turk Kardiyol Dern Ars; 2008 Sep; 36(6):403-6. PubMed ID: 19155646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of different nitrate therapies on long-term clinical outcomes of patients with vasospastic angina: A propensity score-matched analysis.
    Kim CH; Park TK; Cho SW; Oh MS; Lee DH; Seong CS; Gwag HB; Lim AY; Yang JH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC; Ahn J; Carriere KC; Choi SH
    Int J Cardiol; 2018 Feb; 252():1-5. PubMed ID: 29249418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of vasospastic angina--role of nicorandil.
    Kaski JC
    Cardiovasc Drugs Ther; 1995 Mar; 9 Suppl 2():221-7. PubMed ID: 7647026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel drugs for treating angina.
    Jones DA; Timmis A; Wragg A
    BMJ; 2013 Sep; 347():f4726. PubMed ID: 24018101
    [No Abstract]   [Full Text] [Related]  

  • 27. Autonomic antecedents to variant angina exacerbation after beta-blockade withdrawal.
    Chiladakis JA; Alexopoulos D
    J Electrocardiol; 2005 Jan; 38(1):82-4. PubMed ID: 15660353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Controlled evaluation of treatment with an antianginous drug of patients with coronary disease].
    Alberto S; Lavarino A
    Minerva Cardioangiol; 1973 Oct; 21(10):672-6. PubMed ID: 4589191
    [No Abstract]   [Full Text] [Related]  

  • 29. Diagnosis of vasospastic angina: comparison of hyperventilation and cold-pressor stress echocardiography, hyperventilation and cold-pressor stress coronary angiography, and coronary angiography with intracoronary injection of acetylcholine.
    Hirano Y; Uehara H; Nakamura H; Ikuta S; Nakano M; Akiyama S; Ishikawa K
    Int J Cardiol; 2007 Apr; 116(3):331-7. PubMed ID: 16890307
    [No Abstract]   [Full Text] [Related]  

  • 30. [Synergic action of molsidomine and atenolol in patients with exertion angina. Cycloergometric study].
    Gimeno JV; Olagüe J; Bueno FJ; Tellols R; Martín G; Ferrer J
    Med Clin (Barc); 1984 Nov; 83(15):624-8. PubMed ID: 6549203
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experimental and clinical studies with a new coronary and heart-active substance].
    Moll A; Petzel H
    Z Kreislaufforsch; 1967 Jan; 56(1):46-58. PubMed ID: 5595482
    [No Abstract]   [Full Text] [Related]  

  • 32. Nicorandil for angina--an update.
    Drug Ther Bull; 2003 Nov; 41(11):86-8. PubMed ID: 14658416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Method of evaluating the effectiveness of coronary-active preparations].
    Volkov VS
    Kardiologiia; 1974 Feb; 14(2):97-100. PubMed ID: 4825018
    [No Abstract]   [Full Text] [Related]  

  • 34. [Unstable angina pectoris].
    Ioseliani DG
    Sov Med; 1984; (9):38-42. PubMed ID: 6239388
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of refractory vasoespastic angina with corticosteroids. A case report.
    Domínguez Franco AJ; Gómez Doblas JJ; García Pinilla JM; Hernández García JM; Jiménez Navarro M; Alonso Briales JH; de Teresa Galvan E
    Int J Cardiol; 2007 May; 118(2):e51-3. PubMed ID: 17395311
    [No Abstract]   [Full Text] [Related]  

  • 36. [Isoptin studies on normal subjects and patients with coronary disease].
    Knoch G; Schlepper M; Witzleb E
    Med Klin; 1963 Sep; 58(36):1485-9. PubMed ID: 5889185
    [No Abstract]   [Full Text] [Related]  

  • 37. [Successful treatment of vasospastic stenocardia occurring for the 1st time complicated by ventricular fibrillation].
    Borisova EO; Slastnikova ID; Ananich VA; Agapov AA; Kukharchuk VV
    Kardiologiia; 1985 Nov; 25(11):104-6. PubMed ID: 4087661
    [No Abstract]   [Full Text] [Related]  

  • 38. A symposium: A new treatment for angina pectoris and heart failure. October 17, 1987, San Francisco. Proceedings.
    Am J Cardiol; 1989 Jun; 63(21):1J-85J. PubMed ID: 2525318
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy of oral nicorandil in patients with end-stage renal disease: a retrospective chart review after coronary angioplasty in Japanese patients receiving hemodialysis.
    Ishii H; Toriyama T; Aoyama T; Takahashi H; Yamada S; Kasuga H; Ichimiya S; Kanashiro M; Mitsuhashi H; Maruyama S; Matsuo S; Naruse K; Matsubara T; Murohara T
    Clin Ther; 2007 Jan; 29(1):110-22. PubMed ID: 17379051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment and prognosis of vasospastic angina].
    Kijima M; Aikawa K; Sato H; Matsumoto S; Ikeda K
    Nihon Rinsho; 1994 Aug; 52 Suppl(Pt 2):291-4. PubMed ID: 12439983
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.